KANGER 0170 Share Price
RM0.03
klse: Kanger International Berhad
Stock Information
Board : Ace
Shariah : Shariah Compliant
Sector : Building Materials Construction Civil Engineering
Address: 1 & 3, Jalan Alfa Impian 2, Taman Perindustrian Alfa Impian, 43300 Balakong, Selangor
Contact: +603-64130143
Website: https://www.krbamboo.com/
Stock Background
Kanger International Berhad provides green building materials. The Company manufactures and trades horizontal, vertical and stand woven bamboo flooring and related products. Kanger International offers its products to the residential and commercial construction industries.
Profit Analysis: KANGER 0170
|
Result
Quarter Report History
| Date | Revenue,k | PBT,k | Net Profit,k |
|---|---|---|---|
| 29/05/26 | 40,633 | -112,115 | -113,985 |
| 25/02/26 | 4,996 | -356 | -356 |
| 25/11/25 | 13,259 | -507 | -837 |
| 26/08/25 | 16,640 | 404 | 404 |
| 28/05/25 | 7,419 | -290 | -290 |
| 28/05/25 | 8,164 | -406 | -406 |
| 29/11/24 | 5,802 | -14,206 | -14,575 |
| 27/08/24 | 323 | -1,797 | -1,797 |
| 29/05/24 | 9,969 | -727 | -1,464 |
| 26/02/24 | 20,691 | 647 | -382 |
| 29/11/23 | 7,225 | 2,360 | 2,795 |
| 30/08/23 | 6,855 | -1,506 | -836 |
Fundamental
Fundamental Analysis
| Last 4 Quarter Revenue (RM’000) | 73 |
|---|---|
| Last 4 Quarter Net Profit (RM’000) | -114,277 |
| Last 4 Quarter EPS (sen) | -12.93 |
| Last 4 Quarter PER | 0 |
| Last 4 Quarter Dividend (sen) | – |
| Last 4 Quarter Dividend Yield (%) | 0.00 |
| Net Tangible Assets (RM) | 0.28 |
| Goodwill (RM) | 0 |
| Cash (RM’000) | 263 |
| Debt (RM’000) | 0 |
| Total Debt (RM’000) | 36,560 |
| Net Assets (RM’000) | 216,940 |
| Current Ratio | 1.76 |
| Quick Ratio | – |
| Cash Ratio | 0.01 |
Technical
Technical Analysis
| MACD (26 vs 12) | -2.248 |
|---|---|
| Exponential Moving Average 5 | 0.025 |
| Exponential Moving Average 20 | 0.023 |
| Exponential Moving Average 90 | 0.028 |
| Relative Strength Index 14 | 0.50 |
| Stochastic %D 3 | 0.17 |
| Stochastic %K 14 | 0.50 |
27 reviews for KANGER 0170
Show all Most Helpful Highest Rating Lowest Rating
Only logged in customers who have purchased this product may leave a review.
Stock Profit Analysis
-
BNASTRA 7195 ★★★★★RM2.14 - PETRONM 3042 ★★★★★RM3.44
- CMSB 2852 ★★★★★RM1.00
- SUNREIT 5176 ★★★★★RM2.23
Salary Proof
BURSA MALAYSIA –
The Group recorded loss before taxation of RM8 million in Q2 2023 as compare to loss before taxation of RM2.3 million in Q1 2023. Huge amount of losses was recorded in Q2 2023 was mainly due to the Group has incurred non-recurring expenses such as loss on disposal of subsidiaries company of RM10.5 million.
BURSA MALAYSIA –
The Group recorded loss before taxation of RM2.3 million in Q1 2023 as compare to loss before taxation of RM31 million in Q1 2022. High amount of losses was recorded in Q4 2022 was mainly due to the Group has incurred non-recurring expenses such as impairment loss on inventories amounting to RM15.5 million, impairment loss on trade and other receivables amounting to RM24.1 million.
BURSA MALAYSIA –
The Group recorded loss before taxation of RM31.0 million in Q4 2022 as compared to loss before taxation of RM74.8 million in Q3 2022. The increase in revenue was mainly due to the increase in sales in Malaysia in as
a result of the relaxation of movement control order in the current financial quarter.
BURSA MALAYSIA –
The Group recorded loss before taxation of RM74.8million in Q3 2022 as compared to loss before taxation of RM49.1 million in Q2 2022. The decrease in revenue was mainly due to the decrease in sales within PRC and
Malaysia in the current financial quarter.
BURSA MALAYSIA –
The Group recorded loss before taxation of RM49.1million in Q2 2022 as compared to loss before taxation of RM8.1 million in Q1 2022. The significant increase in loss before taxation in Q2 2022 was mainly due to the Group has incurred non-recurring expenses such as recognition of share-based payments amounting to RM3.7 million granted to the directors and employees of the Company, impairment loss on inventories amounting to RM13.3 million, impairment loss on trade and other receivables amounting to RM25.1 million and impairment loss on property, plant and equipment amounting to RM4.7 million in the current financial quarter
BURSA MALAYSIA –
The Group recorded LBT of RM8.1 million in Q1 2022 as compared to LBT of RM19.8 million in Q5 2022. The decrease in LBT in Q1 2022 was mainly driven by the absent on the recognition of some non-recurring expenses in previous quarter Q5 2021 such as impairment loss on trade and other receivables of RM46.9 million, intangible assets written off of RM1.8 million and the share based payment of RM3.9 million although mitigated by the recognition of the fair value gain on investment properties of RM39.2 million in previous quarter
BURSA MALAYSIA –
The Group recorded LBT of RM8.1 million in Q1 2022 as compared to LBT of RM19.8 million in Q5 2022. The decrease in LBT in Q1 2022 was mainly driven by the absent on the recognition of some non-recurring expenses in previous quarter Q5 2021 such as impairment loss on trade and other receivables of RM46.9 million, intangible assets written off of RM1.8 million and the share based payment of RM3.9 million although mitigated by the recognition of the fair value gain on investment properties of RM39.2 million in previous quarter
The Edge –
Kanger International Bhd will receive 10,000 doses of a Covid-19 vaccine developed by state-owned China National Pharmaceutical Group Corp (Sinopharm) for trial purposes. In a bourse filing today, the group said the 10,000 doses of the vaccine will be for trial purposes and that it will be getting the necessary approvals from the relevant authorities. The first batch of vaccines is expected to arrive in May 2021
The Edge –
Kanger Holdongs Bhd has bagged a contract to build two blocks of serviced apartments totalling RM478 million in Genting Highlands. Its subsidiary Kanger Ventures Sdn Bhd, which has entered into a collaboration agreement with Vegetta Champion Sdn Bhd, will be responsible for the entire project management, financial and entire administration of this development. The project is expected to commence in June 2021 and will take approximately 48 months to be completed.
The Edge –
Over at ACE Market-listed Kanger International Bhd, its managing director-cum-deputy chairman Leng Xingmin is no longer a substantial shareholder of the China-based bamboo floor manufacturer after he sold 25 million shares, or a 1.11% stake, on the open market on Jan 15 at 14 sen per share for a total of RM3.5 million. Post-disposal, Leng is left with a 4.01% stake. Leng, a Chinese national, has been paring down his holding in the company over the years. In April 2014, he owned as much as 55.17% of the company.
The Star –
Stocks to watch on Monday include Kanger International Bhd, according to JF Apex Research. Kanger International has diversified into the construction business by signing six deals totalling RM495.9mil. It involves the group undertaking the remaining works at six construction sites in Kuala Lumpur and Pahang, the group said.
The Edge –
Kanger International Bhd has received support from the Ministry of Science, Technology and Innovation to purchase Covid-19 vaccines for private-sector use in Malaysia. The ministry’s agency National Institutes of Biotechnology Malaysia (NIBM) had no objection for the company to cooperate with China National Pharmaceutical Group Corp (Sinopharm) on the purchase of the vaccines.